Literature DB >> 8853215

The role of serotonergic receptors in the effects of mu opioids in squirrel monkeys responding under a titration procedure.

K R Powell1, L A Dykstra.   

Abstract

This experiment was conducted to determine whether drugs acting on brain serotonin modulate the effects of the mu opioid, morphine, as measured by the squirrel monkey shock titration procedure and, if so, whether serotonergic modulation is mediated via specific 5HT receptor subtypes. Under this procedure, electric shock was delivered to the monkey's tail and scheduled to increase once every 15 s from 0.01 to 2.0 mA in 30 steps. Five responses on a lever during the 15-s shock period terminated the shock for 15 s, after which the shock resumed at the next lower intensity. The intensity below which monkeys maintained shock 50% of the time (median shock level or MSL) and rate of responding (RR) in the presence of shock were determined under control conditions and after administration of morphine alone and in combination with various serotonergic compounds. Morphine increased median shock level and decreased rate of responding in a dose-dependent manner. These effects of morphine was attenuated by the 5HT1A receptor agonists, 8-OH-DPAT [(+)-8-hydroxy-2(di-n-propylamino tetralin HBr] and ipsapirone. The effects of morphine were not altered by the 5HT1A receptor antagonist, NAN-190 [1-(2-methoxyphenyl-4-[4-(2-phthalimido) butyl] piperazine HBr], and 5HT2 receptor antagonist, ketanserin, the 5HT3 receptor antagonist, MDL 72222 [3-tropanyl-3,5-dichlorobenzoate], the alpha 2 adrenergic antagonist, yohimbine, or the alpha2 adrenergic agonist, clonidine. These results suggest that 5HT1A receptors may be involved in the effects of morphine in the shock titration procedure, whereas 5HT2, 5HT3 and alpha 2 adrenergic receptors do not appear to play a role in morphine's effects in this procedure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8853215     DOI: 10.1007/bf02246409

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  60 in total

1.  Evaluation of the interactions of serotonergic and adrenergic drugs with mu, delta, and kappa opioid binding sites.

Authors:  P J Monroe; S E Perschke; T Crisp; D J Smith
Journal:  Neurosci Lett       Date:  1991-12-09       Impact factor: 3.046

2.  5-hydroxytryptamine (HT)1A receptors and the tail-flick response. III. Structurally diverse 5-HT1A partial agonists attenuate mu- but not kappa-opioid antinociception in mice and rats.

Authors:  M J Millan; F C Colpaert
Journal:  J Pharmacol Exp Ther       Date:  1991-03       Impact factor: 4.030

3.  Intrathecal coadministration of clonidine with serotonin receptor agonists produces supra-additive visceral antinociception in the rat.

Authors:  R M Danzebrink; G F Gebhart
Journal:  Brain Res       Date:  1991-07-26       Impact factor: 3.252

4.  The binding spectrum of narcotic analgesic drugs with different agonist and antagonist properties.

Authors:  J Magnan; S J Paterson; A Tavani; H W Kosterlitz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-06       Impact factor: 3.000

5.  Effect of selective destruction of serotonergic neurons in nucleus raphe magnus on morphine-induced antinociception.

Authors:  J S Mohrland; G F Gebhart
Journal:  Life Sci       Date:  1980 Dec 22-29       Impact factor: 5.037

6.  Do opioids evoke the release of serotonin in the spinal cord? An in vivo microdialysis study of the regulation of extracellular serotonin in the rat.

Authors:  Fátima F Matos; Hans Rollema; Jessica L Brown; Allan I Basbaum
Journal:  Pain       Date:  1992-03       Impact factor: 6.961

7.  Effects of single and repeated daily injections of morphine, clonidine and l-nantradol on responding of squirrel monkeys under escape titration.

Authors:  J B Smith
Journal:  J Pharmacol Exp Ther       Date:  1985-07       Impact factor: 4.030

8.  Effects of the putative 5-hydroxytryptamine1A antagonists BMY 7378, NAN 190 and (-)-propranolol on serotonergic dorsal raphe unit activity in behaving cats.

Authors:  C A Fornal; F Marrosu; C W Metzler; K Tada; B L Jacobs
Journal:  J Pharmacol Exp Ther       Date:  1994-09       Impact factor: 4.030

9.  Spinal infusion of opiate and alpha-2 agonists in rats: tolerance and cross-tolerance studies.

Authors:  C W Stevens; M S Monasky; T L Yaksh
Journal:  J Pharmacol Exp Ther       Date:  1988-01       Impact factor: 4.030

10.  MDL 72222: a potent and highly selective antagonist at neuronal 5-hydroxytryptamine receptors.

Authors:  J R Fozard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-05       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.